Up to 40% of Cancer Cases Are Preventable: New WHO Study
Nearly four in ten cancer cases globally – around 7.1 million diagnoses in 2022 – could be prevented, according to a new analysis released ahead of World Cancer Day, February 4th. The comprehensive study, conducted by the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC), examined 30 preventable causes, ranging from well-established risk factors like tobacco and alcohol to, for the first time, nine cancer-causing infections. The findings underscore the significant potential for reducing the global cancer burden through targeted prevention strategies.
The Preventable Burden: A Global Snapshot
The analysis, drawing on data from 185 countries and encompassing 36 different cancer types, identifies tobacco apply as the leading preventable cause of cancer worldwide, accounting for 15% of all new cases. Infections are responsible for 10% and alcohol consumption for 3%. Three cancers – lung, stomach, and cervical – collectively represent nearly half of all preventable cancer cases in both men and women globally. This isn’t simply about avoiding illness; the estimated global cost of cancer is projected to reach $25 trillion over the next 30 years, highlighting the economic benefits of prevention as well.
Lung cancer’s strong link to smoking and air pollution, stomach cancer’s association with Helicobacter pylori infection, and cervical cancer’s overwhelming connection to the human papillomavirus (HPV) are particularly striking. These findings reinforce the importance of public health initiatives focused on smoking cessation, air quality improvement, and HPV vaccination programs. You can find more information about HPV and cancer prevention on the Centers for Disease Control and Prevention (CDC) website.
Gender and Regional Disparities
The burden of preventable cancer differs significantly between men and women. The study revealed that 45% of new cancer cases in men are linked to preventable causes, compared to 30% in women. Among men, smoking is the dominant factor, responsible for an estimated 23% of all new cases, followed by infections (9%) and alcohol (4%). For women, infections account for 11% of cases, with smoking at 6% and high body mass index at 3%.
Geographical variations are as well pronounced. Preventable cancers range from 24% in North Africa and West Asia to 38% in sub-Saharan Africa among women. Among men, the highest burden is observed in East Asia (57%), while the lowest is in Latin America and the Caribbean (28%). These differences reflect varying levels of exposure to risk factors, as well as disparities in socioeconomic development, national prevention policies, and the capacity of health systems. The IARC provides detailed cancer statistics and information by country on their Global Cancer Observatory website.
Beyond Lifestyle: The Role of Infections
A key advancement in this analysis is the inclusion of cancer-causing infections. The study highlights the significant contribution of infections to the global cancer burden, accounting for approximately 10% of all cases. This underscores the importance of vaccination programs against viruses like HPV and hepatitis B, as well as strategies to prevent and treat infections like Helicobacter pylori. The WHO emphasizes the critical role of vaccination in cancer prevention, with resources available on their cancer fact sheet.
Understanding the Study: Methods and Limitations
The study, published in Nature, utilized data from 185 countries and 36 cancer types to estimate the proportion of cases attributable to 30 preventable causes. Researchers employed a comparative risk assessment framework, analyzing exposure levels to various risk factors and their associated cancer risks. While this analysis provides a comprehensive overview, it’s important to acknowledge its limitations. The study relies on available data, which may vary in quality and completeness across countries. Establishing a causal link between specific exposures and cancer development can be complex, as many cancers are multifactorial, influenced by a combination of genetic, environmental, and lifestyle factors. The authors acknowledge that the estimates are subject to uncertainty and should be interpreted with caution.
What Does ‘Preventable’ Actually Mean?
It’s crucial to understand that “preventable” doesn’t necessarily mean a cancer case could have been entirely avoided. It signifies that the risk of developing cancer could have been reduced by modifying or eliminating exposure to a specific risk factor. For example, while not everyone who smokes will develop lung cancer, a significant proportion of lung cancer cases are directly attributable to smoking, and those cases could have been prevented by not smoking. This distinction is important when interpreting the study’s findings and developing effective prevention strategies.
A Multi-Sectoral Approach to Prevention
The findings emphasize the need for comprehensive, context-specific prevention strategies. These strategies should include robust tobacco control measures, alcohol regulation, vaccination programs, improved air quality, safer workplaces, and environments that promote healthy diets and physical activity. Addressing these preventable causes requires coordinated action across multiple sectors, including health, education, energy, transport, and labor.
Reducing preventable risk factors not only lowers cancer incidence but also reduces long-term healthcare costs and improves overall population health and well-being. The WHO and IARC are actively working to strengthen cancer prevention, early detection, treatment, and palliative care worldwide, providing technical guidance and supporting governments in improving access to care.
Looking Ahead: Strengthening Surveillance and Policy
The release of this analysis is not an endpoint, but rather a call to action. Continued investment in cancer research and surveillance is essential to refine our understanding of risk factors and improve prevention strategies. Strengthening data collection and monitoring systems, particularly in low- and middle-income countries, will be crucial for tracking progress and identifying emerging trends. Translating research findings into effective policies and interventions requires strong political commitment and collaboration between governments, healthcare professionals, and civil society organizations. The IARC’s ongoing work in cancer surveillance and research will continue to inform global efforts to reduce the cancer burden.